Cequr receruitment agency news walesAll the latest recruitment agency news in Wales.

Swiss medical manufacturer CeQur is to launch a new Welsh subsidiary . The company has created a new insulin infusion device for people with type 2 diabetes.

Wales-based Arthurian Life Sciences provided funding together with Woodford Investment Management. Existing investors including Endeavour Vision, Schroder & Co Banque SA and VI Partners also participated.

The funding will also be used to support further clinical and regulatory activities, manufacturing scale-up and commercial operations for a planned European and US 2016 launch of the company’s three-day insulin infusion device, PaQ.

PaQ is a simple patch-like insulin infusion device which could potentially offer an alternative to insulin injections for people with type 2 diabetes.

Following the launch in Wales, CeQur will start a clinical study in collaboration with University of Swansea, scheduled to begin enrollment in 2016.

To read more visit the Arthrian Life Sciences website.

© Sigma Recruitment Ltd. 2020 Company Number 5659374 | VAT No: 869514188 | Terms of Service | Cookie Policy | Privacy Policy